Arbutus Biopharma Corp (ABUS)
3.955
+0.10
(+2.46%)
USD |
NASDAQ |
Nov 05, 16:00
3.955
0.00 (0.00%)
After-Hours: 16:28
Arbutus Biopharma Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2011 | -5.30% |
| June 30, 2011 | -40.62% |
| March 31, 2011 | -29.84% |
| December 31, 2010 | |
| September 30, 2010 | 49.69% |
| June 30, 2010 | -108.5% |
| March 31, 2010 | -121.3% |
| December 31, 2009 |
| Date | Value |
|---|---|
| September 30, 2009 | |
| June 30, 2009 | -15.97% |
| March 31, 2009 | -25.62% |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | -2.66% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 74.73% |
| GlycoMimetics Inc | -- |
| FibroGen Inc | 89.78% |
| Cidara Therapeutics Inc | -- |
| Cue Biopharma Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -64.55% |
| Return on Assets | -48.78% |
| Return on Invested Capital | -64.55% |
| Profit Margin (Quarterly) | -1.15K% |
| Operating Margin (Quarterly) | -1.24K% |
| Return on Net Operating Assets | -938.2% |